We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging

By HospiMedica International staff writers
Posted on 09 Apr 2025

Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. More...

Made of carbon with an atomic number of six, diamonds are particularly similar to biological tissue, which makes them highly suitable for radiation detection. As a result, diamonds have been widely researched as radiation detectors in nuclear engineering, nuclear fusion, high-energy physics, and medical applications. Until the 1990s, studies typically relied on select natural diamonds. However, since the early 2000s, improvements in chemical vapor deposition (CVD) technology have enabled the creation of high-purity synthetic diamonds, leading to better detector performance. Single-crystal CVD diamonds are noted for their high sensitivity and superior spectral qualities, while polycrystalline CVD diamonds, which offer larger detection areas, are less sensitive and provide poorer spectral characteristics compared to single-crystal diamonds.

Orbray Co., Ltd. (Tokyo, Japan) has developed a cutting-edge radiation detector based on its proprietary high-quality, large-diameter single-crystal diamond technology. The unique physical properties of diamonds, including their radiation resistance, allow Orbray’s diamond detectors to perform effectively in high-radiation environments where traditional detectors would deteriorate. Additionally, because diamond's composition closely matches that of biological tissue, it is especially beneficial for medical applications, such as radiation diagnostics and therapy. Orbray’s diamond-based detector has demonstrated the capability to perform precise measurements across a broad spectrum of radiation types, ranging from low-energy diagnostic X-rays to high-energy therapeutic X-rays.

In 2021, Orbray developed a 2-inch diameter high-quality (100) free-standing diamond substrate using its proprietary step-flow growth method. Leveraging this diamond, the company has created radiation detectors that exhibit high sensitivity and excellent spectroscopic performance in medical X-ray systems. The detector can be scaled for larger configurations, ensuring ultra-high sensitivity. Orbray is committed to further developing these products and is continuing to conduct user evaluations.

Related Links:
Orbray Co., Ltd.


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
Vessel Sealing Instrument
ERGOseal
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.